Riociguat API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Adempas
Category: Active Pharmaceutical Ingredient
Riociguat is an oral soluble guanylate cyclase stimulator for pulmonary hypertension. It is sourced by generic formulators, CDMOs and licensed importers preparing generic tablets.
Manufacture or export Riociguat API? List it or send an offer →
Product Description:
Riociguat stimulates soluble guanylate cyclase, the enzyme that nitric oxide normally switches on, raising cyclic GMP so that the blood vessels in the lungs relax. It is approved for adults with chronic thromboembolic pulmonary hypertension that is inoperable or persists after surgery, and for pulmonary arterial hypertension (WHO Group 1) (reference brand: Adempas).
Specification at a glance
| Traded form | Free base; white to yellowish, crystalline and non-hygroscopic, with strongly pH-dependent solubility. |
|---|---|
| CAS number | 625115-55-1 |
| Molecular formula | C20H19FN8O2 |
| Molecular weight | 422.4 g/mol |
| Pharmacopoeia | EDQM supplies a riociguat Ph. Eur. reference standard, which points to a Ph. Eur. text (not verified against the Ph. Eur. itself). No USP or JP monograph found. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 6 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Generics/biosimilars on the market (Oct 2026). European Union: Patent expiry; entry not confirmed (2028).
Handling and quality points
The label describes solid riociguat as stable to temperature, light and humidity, so storage is straightforward. More attention goes on crystal form, as more than one solid form is known, and on particle size, because the tablets contain very little drug and content uniformity depends on it. Riociguat carries an embryo-foetal toxicity warning, so occupational exposure controls and suitable containment for weighing and blending apply.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Riociguat API — third party manufacturing & bulk supply
Riociguat API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Riociguat API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Riociguat API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Riociguat API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
A GMP certificate, specification and certificate of analysis, and a US DMF letter of access, EU ASMF or CEP if one is available. Buyers also ask for solid-form and particle size data, stability results, and nitrosamine and residual solvent risk assessments.
Riociguat can exist in more than one crystalline form, and the reference product uses one defined form. Ask the supplier which form it makes, how it is confirmed by XRPD, and whether the material is milled or micronised to a set particle size distribution suited to low-strength tablets.
It can. We connect licensed manufacturers, CDMOs and research teams with GMP-compliant riociguat makers, and we check the supplier's paperwork before passing on an enquiry. Your company stays anonymous until both sides are happy to proceed.
Related Products
Carfilzomib API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Kyprolis
View DetailsAcalabrutinib API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Calquence
View DetailsNiraparib Tosylate Monohydrate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Zejula
View DetailsFerumoxytol API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Feraheme, Rienso
View DetailsMonomethyl Auristatin E (MMAE) API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Adcetris, Padcev, Polivy, Tivdak
View DetailsFidaxomicin API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Dificid, Dificlir
View DetailsNivolumab Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Opdivo
View DetailsBenralizumab Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Fasenra
View DetailsUsually answered within 48 hours | GMP documents shared before you commit